OpenEvidence, the ‘ChatGPT for Doctors,’ Hits $15 Billion Valuation Following Major Funding Round

OpenEvidence, known as the ‘ChatGPT for doctors,’ has secured nearly $800 million in funding over the past year. This impressive capital influx comes from prominent investors including Nvidia, Thrive Capital, Kleiner Perkins, a16z, and Sequoia Capital, leading to a $15 billion valuation for the startup.